These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6751958)

  • 1. [Controlled double-blind study for the determination of the effect of Tebonin forte in patients with cerebrovascular insufficiency].
    Eckmann F; Schlag H
    Fortschr Med; 1982 Aug; 100(31-32):1474-8. PubMed ID: 6751958
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ginkgo biloba flavone glycoside. Therapeutic possibilities for cerebral insufficiency].
    Haan J; Reckermann U; Welter FL; Sabin G; Müller E
    Med Welt; 1982 Jul; 33(27):1001-5. PubMed ID: 7144495
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary degenerative dementia: therapy with Ginkgo biloba extract. Placebo-controlled double-blind and comparative study].
    Weitbrecht WU; Jansen W
    Fortschr Med; 1986 Mar; 104(9):199-202. PubMed ID: 3516818
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disorders of brain performance of vascular origin. Randomized double-blind study of the effectiveness of Gingko biloba extract].
    Halama P; Bartsch G; Meng G
    Fortschr Med; 1988 Jun; 106(19):408-12. PubMed ID: 3061905
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Ginkgo biloba extract in arterial occlusive disease. Randomized placebo controlled crossover study].
    Rudofsky G
    Fortschr Med; 1987 Jul; 105(20):397-400. PubMed ID: 3301603
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cerebral insufficiency--treatment with Ginkgo-biloba extract. Time of onset of effect in a double-blind study with 60 inpatients].
    Eckmann F
    Fortschr Med; 1990 Oct; 108(29):557-60. PubMed ID: 2242846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of tanakan on central nervous system function in patients with the residual manifestations of stroke].
    Kuznetsova SM; Glazovskaia II; Kuznetsov VV
    Lik Sprava; 1997; (6):132-4. PubMed ID: 9589957
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimization of placebos for double-blind clinical trials. Experience with a phytopharmaceutical.
    Knipschild PG; Hoerr R; Oschmann R; van Rossum E; van Dongen MC
    Arzneimittelforschung; 1998 Oct; 48(10):1033-6. PubMed ID: 9825123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antihypoxic and antioxidant action of medicinal plants as the basis for their use in destructive brain diseases].
    Pospelova ML; Barnaulov OD
    Fiziol Cheloveka; 2000; 26(1):100-6. PubMed ID: 10752298
    [No Abstract]   [Full Text] [Related]  

  • 10. [Microcirculation in parenteral Ginkgo biloba extract therapy].
    Költringer P; Eber O; Klima G; Rothlauer W; Wakonig P; Langsteger W; Lind P
    Wien Klin Wochenschr; 1989 Mar; 101(6):198-200. PubMed ID: 2652887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ginkgo-special-extract EGb 761 in peripheral arterial occlusive diseases stage IIb according to Fontaine].
    Blume J; Kieser M; Hölscher U
    Fortschr Med; 1998 Dec; 116(35-36):36-7. PubMed ID: 10023188
    [No Abstract]   [Full Text] [Related]  

  • 12. [Double blind study of the hypoxia protective effect of a standardized Ginkgo biloba preparation after repeated administration in healthy subjects].
    Schaffler K; Reeh PW
    Arzneimittelforschung; 1985; 35(8):1283-6. PubMed ID: 3907639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Future of the therapy of dementia--current data on Ginkgo-Special Extract EGB 761].
    Nervenarzt; 1998 Apr; 69(4 Suppl Die Zukunf):1-8. PubMed ID: 9595554
    [No Abstract]   [Full Text] [Related]  

  • 14. Ginkgo biloba for cerebral insufficiency.
    Kleijnen J; Knipschild P
    Br J Clin Pharmacol; 1992 Oct; 34(4):352-8. PubMed ID: 1457269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of an extract of ginkgo biloba (Tebonin) in the therapy of cerebral vascular diseases].
    Montanini R; Gaspari G
    Minerva Cardioangiol; 1969 Dec; 17(12):1096-102. PubMed ID: 5373481
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age].
    Hopfenmüller W
    Arzneimittelforschung; 1994 Sep; 44(9):1005-13. PubMed ID: 7986236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials.
    Rejali D; Sivakumar A; Balaji N
    Clin Otolaryngol Allied Sci; 2004 Jun; 29(3):226-31. PubMed ID: 15142066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A double-blind comparison of a sulfurated mucopolysaccharide and placebo in the treatment of elderly patients with cerebrovascular insufficiency].
    Astengo F; Fontana L; Balestreri R
    Clin Ter; 1987 Feb; 120(3):219-26. PubMed ID: 2461828
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tanakan in the treatment of primary manifestations of insufficiency of brain blood supply].
    Timerbaeva SL; Suslina ZA; Bodareva EA; Fedin PA; Korepina OS; Pervosvanskiĭ BE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(8):24-8. PubMed ID: 10983363
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical effect of Encephabol (pyritinol) in the treatment of cerebrovascular disorders.
    Tazaki Y; Omae T; Kuromaru S; Ohtomo E; Hasegawa K; Mori A; Kurihara M; Kutsusawa N; Okada T
    J Int Med Res; 1980; 8(2):118-26. PubMed ID: 6989681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.